Skip to main content

Belimumab Dosage

Medically reviewed by Drugs.com. Last updated on Apr 5, 2023.

Applies to the following strengths: 200 mg/mL; 120 mg; 400 mg

Usual Adult Dose for Systemic Lupus Erythematosus

IV: 10 mg/kg IV every 2 weeks for the first 3 doses and every 4 weeks thereafter
Subcutaneous: 200 mg subcutaneously once a week

Comments:


Use: For the treatment of patients with active systemic lupus erythematosus (SLE) who are receiving standard therapy

Usual Adult Dose for Lupus Nephritis

IV: 10 mg/kg IV every 2 weeks for the first 3 doses and every 4 weeks thereafter
Subcutaneous:


Comments:

Use: For the treatment of patients with active lupus nephritis who are receiving standard therapy

Usual Pediatric Dose for Systemic Lupus Erythematosus

5 years and older: 10 mg/kg IV every 2 weeks for the first 3 doses and every 4 weeks thereafter

Uses:

Usual Pediatric Dose for Lupus Nephritis

5 years and older: 10 mg/kg IV every 2 weeks for the first 3 doses and every 4 weeks thereafter

Uses:

Renal Dose Adjustments

Renal dysfunction: No adjustment recommended

Liver Dose Adjustments

Liver dysfunction: No adjustment recommended

Precautions

CONTRAINDICATIONS:


Safety and efficacy of IV administration have not been established in patients younger than 5 years. Safety and efficacy of subcutaneous administration have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
IV Administration:


Subcutaneous Administration:

Storage requirements:
IV Infusion:

Subcutaneous Injection:

Reconstitution/preparation techniques:

IV compatibility:

General:

Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.